Where Does Canopy Growth Corp (CGC) Stock Fall in the Drug Manufacturers - Specialty & Generic Field After It Has Fallen -8.07% This Week?

The 33 rating InvestorsObserver gives to Canopy Growth Corp (CGC) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 71 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, CGC’s 33 overall rating means the stock scores better than 33 percent of all stocks.

CGC has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on CGC!

See Full CGC Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Canopy Growth Corp Stock Today?

Canopy Growth Corp (CGC) stock is trading at $18.34 as of 1:01 PM on Tuesday, Jul 27, a loss of -$1.37, or -6.96% from the previous closing price of $19.71. The stock has traded between $18.31 and $19.77 so far today. Volume today is 2,919,411 compared to average volume of 2,507,893. Click Here to get the full Stock Report for Canopy Growth Corp stock.